Worldwide: Patent

Subscribe

Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.

Eastern District Of Texas Tosses Random Chat's "Random Chat" Patent Under Section 101

If you defend patent lawsuits or have ever been a defendant, you've likely heard from Random Chat LLC...

United States IP

HK

Holland & Knight

English High Court Rules No SPC Based On Authorisation Of Monotherapy A Where A+B Was Authorised First

In Laboratorios Leon Farma SA v The Comptroller General of Patents ([2026] EWHC 663 (Ch)), the High Court of England and Wales has reached an important conclusion relating...

United States IP

JA

J A Kemp LLP

Gene Therapy And US Patent Eligibility Update: REGENXBIO, Inc. v. Sarepta Therapeutics, Inc.

In the US, laws of nature and natural phenomena are considered to be "patent ineligible."

United States IP

JA

J A Kemp LLP

When 10% Is Enough: Director Denies IPR Over Foreign Sovereign Ownership Interest

Discretionary denial at the PTAB continues to evolve, and a recent decision by the USPTO Director adds another important dimension.

B

BakerHostetler

The USPTO Changed The Rules For Digital Design Patents – Strategic Insights On What It Means For Your Business

United States IP

B

BakerHostetler

US Firms: China No Longer An 'Afterthought'

MB

Mayer Brown

FRAND Quarterly: Navigating The Global SEP Landscape – March 2026

W

WilmerHale

USPTO Final Rule Imposes Mandatory U.S. Counsel Requirement For Foreign Patent Applicants

United States IP

BT

Barnes & Thornburg LLP

USPTO Director's Memo Highlights New Considerations For US Manufacturers In AIA Patent Challenges

United States IP

BL

Butzel Long

MSTM, LLC Et Al. v. AB Sciex LLC D/b/a SCIEX (D. Mass. 23-cv-11121)

United States IP

LA

Lando & Anastasi

Update: Janssen Files BPCIA Complaint Against Bio-Thera And Accord Related To Golimumab Biosimilar

United States IP

GP

Goodwin Procter LLP

USPTO Updates Guidance On Patentability Of Computer-Generated Interfaces And Icons

United States IP

LD

Lerner David

USPTO Updates Guidance For More Flexible Examination Of Design Patent Applications Related To Computer-Generated Interfaces And Icons

United States IP

OM

Oblon, McClelland, Maier & Neustadt, L.L.P

AI Is Rewriting The Rules Of IP Law

United States IP

BT

Barnes & Thornburg LLP

Gabriel Pinilla On Coffee Shops: La Voz De Los Ruferos (Podcast)

United States Real Estate

Aa

Adams and Reese

401(k) And IRA Contribution Limits For 2026: Retirement Savings, Adjustments For Inflation, And SECURE 2.0 Changes American Taxpayers Must Know About

United States Tax

RS

Rotfleisch & Samulovitch P.C.

Colorado "Opt-Out" Litigation – Petition For Rehearing En Banc And Amicus Briefs In Support

United States Finance

BS

Ballard Spahr LLP

What Europe's Renewable Energy Struggles Can Teach U.S. Regulators About Dispute System Design

United States Litigation

J

JAMS

Back To School 2025: Title IX Updates And How ADR Can Help Universities Resolve Disputes (Podcast)

United States Litigation

J

JAMS

Unintended Consequences: GAO Report Questions Impact Of Exercising March-In Rights For Drug Pricing

The Result: The GAO's findings on the yet-to-be-finalized NIST guidance reveal a lack of interagency consensus and potential risks of undermining the broader innovation ecosystem enabled by Bayh-Dole.

United States Healthcare

JD

Jones Day

Mayer Brown Establishes PTAB Precedent In Securing Discretionary Denial Against Foreign-Government-Backed Petitioner

On March 18, 2026, the Director of the US Patent and Trademark Office (USPTO) issued a precedential decision denying institution of an inter partes review (IPR) in IPR2025-01579.

United States IP

MB

Mayer Brown

Delaware Supreme Court Reverses Chancery Court Decision Invalidating Governance Provisions Of A Stockholder Agreement

Securities Snapshot highlights notable developments in securities law, covering litigation and enforcement matters, legislation, and regulatory guidance.

United States Commercial

GP

Goodwin Procter LLP

From Lab To Patent: Elevating Women's Contributions To Innovation

Women's History Month is an opportunity not only to celebrate women's contributions to innovation, but also to examine why those contributions remain underrepresented in the patent system.

United States IP

NM

Nelson Mullins Riley & Scarborough LLP

Federal Circuit Affirms Noninfringement Where Expert's Analysis Of Means-Plus-Function Claim Failed To Account For Disclosed Structure

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

INFORMATIVE: No Discretionary Denial Where Prior IPR Suggests Material Error By Office

United States IP

JD

Jones Day

Antibody-Drug Conjugates

United States IP

OM

Oblon, McClelland, Maier & Neustadt, L.L.P

New USPTO Memorandum Adds Domestic Manufacturing And Small Business Factors To PTAB Institution Analysis

United States IP

CM

Crowell & Moring LLP

Hidden Risks In Patent Portfolios: Obviousness-Type Double Patenting, Terminal Disclaimers & JRAs Explained

United States IP

SH

Stites & Harbison PLLC

Home Office, New Venue: The Hidden Litigation Risk Of Remote Work

United States IP

BL

Butzel Long

USPTO Director Squires Adds Three New Discretionary Factors For Institution Decisions

United States IP

AF

ArentFox Schiff

The Power Of Policy: Fintiv Remains Intact At The PTAB

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

FDA Moves To Streamline Biosimilar Development: The Implications For Regulatory And IP Strategy

United States IP

SA

Skadden Arps Slate Meagher & Flom

The Rise Of Trademark Scams: How Small Businesses Can Spot And Stop Them Before It's Too Late

United States IP

PC

Pender & Coward

USPTO Director Squires Adds Three New Discretionary Factors For Institution Decisions

On March 11, US Patent and Trademark Office (USPTO) Director John A. Squires issued a Memorandum setting forth three additional discretionary factors for Inter Partes Review...

United States IP

AF

ArentFox Schiff

The Power Of Policy: Fintiv Remains Intact At The PTAB

In Apple Inc. v. Squires, No. 24-1864 (Fed. Cir. Feb. 13, 2026), the Federal Circuit affirmed the Northern District of California's ruling that the USPTO Director's NHK-Fintiv framework...

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

FDA Moves To Streamline Biosimilar Development: The Implications For Regulatory And IP Strategy

The FDA issued updated guidance on the requirements for biosimilar sponsors seeking to use foreign comparator products in clinical studies.

United States IP

SA

Skadden Arps Slate Meagher & Flom

The Rise Of Trademark Scams: How Small Businesses Can Spot And Stop Them Before It's Too Late

A business owner opens their inbox to find a message warning that someone else is about to register their company name as a federal trademark.

United States IP

PC

Pender & Coward

Transatlantic Patent Litigation: When Should You File In Europe?

European Union IP

MB

Mayer Brown

Manufacturing Matters: The USPTO's New Discretionary Institution Factors

USPTO institution decisions are no longer just about prior art. Over the past year, the Director has steadily expanded discretionary institution analysis to account for broader policy considerations...

United States IP

B

BakerHostetler

Fast‑Forward To Ineligibility: Federal Circuit Invalidates Web‑Conferencing Patent Under § 101

In US Pat. No. 7,679,637 LLC v. Google LLC, No. 2024-1520, 2026 WL 174922 (Fed. Cir. Jan. 22, 2026)...

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Federal Circuit Refuses To Construe "Configured For" As More Than "Capable Of"

In In re Blue Buffalo Enterprises, Inc., No. 2024-1611 (Fed. Cir. Jan. 14, 2026), the Federal Circuit affirmed the PTAB's decision affirming the Examiner's obviousness...

United States IP

OM

Oblon, McClelland, Maier & Neustadt, L.L.P

JONES DAY TALKS®: Women In IP – Supreme Court Denies Review Of Thaler V. Perlmutter: AI Authorship Questions Remain (Podcast)

In early March, the U.S. Supreme Court denied certiorari in Thaler v. Perlmutter, continuing the standard that only works created by a human can receive U.S. copyright protection.

United States IP

JD

Jones Day

Increased Flexibility For Graphical User Interface Design Patent Applicants

United States IP

FL

Foley & Lardner

The Doctrine Of Inherency In The Context Of An Obviousness Analysis

United States IP

OM

Oblon, McClelland, Maier & Neustadt, L.L.P

IPR And PGR Institution Decisions – America First?

United States IP

SP

Squire Patton Boggs LLP

Patenting AI Discoveries In Life Sciences: Overcoming Eligibility, Disclosure, And Inventorship Challenges

United States IP

TS

Taft Stettinius & Hollister

The UPC's First Referral To The CJEU

European Union IP

KL

Herbert Smith Freehills Kramer LLP

Champagne Wishes And Caviar Dreams – Can Two CAVIAR Marks For Jewelry Coexist?

United States IP

SS

Seyfarth Shaw LLP

Federal Circuit Reverses JMOL And Exclusion Of Experts Under Daubert

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

IP Damages Trends: Tools Of Apportionment

United States IP

N

NERA

Backend Optimization, Frontline Compensation: Clarifying Reasonable Royalty Damages

United States IP

II

Irwin IP

USPTO Releases Supplemental Guidance On Graphical User Interface And Icon Design Eligibility

United States IP

DS

Dinsmore & Shohl

Federal Circuit Patent Watch: Reasonable Royalty Not Necessarily Unreliable When It Uses Royalty Base Associated With Unaccused Products

United States IP

W

WilmerHale

Made In The USA? USPTO Adds Manufacturing And Small-Business Factors To PTAB Discretion

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

G 1/25: Enlarged Board Of Appeal Issues Preliminary Opinion On Amendment Of The Description

United States IP

JA

J A Kemp LLP

Chief Judge Signals Changes May Be Coming For The Ordinary Observer Test

United States IP

JD

Jones Day

Squires Again Broadens Discretion For Post-Grant Proceedings

United States IP

AV

Axinn Veltrop & Harkrider

See more

Highlighted Content

Parallel Imports, A Global Phenomenon, And A Very Grey Area Regarding International Trade

United States International

BG

Braumiller Law Group, PLLC

Knowing What's Ahead: Dispute Resolution Planning For Startups In The New Age Of Generative AI

United States Litigation

J

JAMS

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Latest Videos

See more

Patent Protection In A Borderless World (Video)

AP

Arnold & Porter

Critical IP Litigation Lessons For In-House Legal And Innovation Leaders 2025 Webinar (Video)

BK

Brooks Kushman

2025 Video Game Development Primer: Is Your Studio Ready For New Legal Realities? (Video)

G

Gamma Law

Update On Plausibility – A Review Of Case Law In Europe Following G2/21 (Video)

JA

J A Kemp LLP

Licensing University Tech? Critical IP & Agreement Tips (Avoid Patent Pitfalls!) (Video)

C

Crowley Law LLC

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More